Mountain Wai Shan: Increase Market Development Efforts in Emerging Countries and Participate in Market Competition in Compliance with the Law | Direct Performance Meeting

① “Although tendering and procurement have been delayed, procurement demand itself has not been affected. As this year's rectification becomes normalized, it is expected that the postponed procurement projects will gradually resume.” ② “The company's products have been sold to 75 countries and regions around the world, and the most impressive growth performance is still developing countries.”

cls.cnMay 13 17:26

Looking for the 3 billion market? Shengxiang Biological Water Test Rapid Drug Sensitivity Test Track

① “We still do it in the form of strategic investment rather than financial investment. Newly established companies are not included in the scope of the company's statements.” ② If Hunan Shengwei Sumin's subsequent business becomes more mature, it is not ruled out that Shengxiang Biotech will take more actions other than strategic investment.

cls.cnMay 9 15:11

Deciphering the new investment trends of social security funds in the first quarter: the top ten tradable shareholders added to 220 individual stocks, and Inke Healthcare received the largest number of shareholders

① The first quarterly report of A-share listed companies was revealed, and a total of 667 shares of the top ten tradable shareholders were revealed; ② Among them, the Social Security Fund entered the list of the top ten tradable shareholders of 220 individual shares, with Inke Healthcare receiving the most additional holdings and the list of individual stocks with more than 2 additional holdings (attached table); ③ Zhejiang Electric Power received the most new shares in the first quarter, and Wanhua Chemical received the highest market value of new holdings.

cls.cnMay 2 09:42

Dental product revenue declines year by year, and Aojing Medical's foreign acquisitions extend to implants

① In recent years, dental products are the only products among the three main products whose revenue has declined year by year, and gross margin has also declined year by year. ② The acquisition of a brand imported from Germany is expected to increase the technology and market share of Aojing Medical.

cls.cnApr 26 13:22

The lawsuit extends to the rival base of the industry, and the dispute between Egg Biotech and the shareholders of the subsidiary intensifies

① Recently, the small and medium shareholders of Jingchuan Diagnostics were sued by the small and medium shareholders of Jingchuan Diagnostics, and this is only one part of the fight between the two sides; ② Jingchuan Diagnostics made an exclusive response to the Financial Federation reporter saying that several lawsuits have only been filed in August of last year, and that management and employees expect the dispute to be resolved as soon as possible; ③ the industry believes that the intention to continue to acquire Gidao Biotech is not strong, or that it has caused a “soft confrontation” with Jingchuan Diagnosis.

cls.cnApr 25 23:34

Can Kangtuo Medical's core business grow year by year to solve the dilemma of increasing revenue or not increasing profit? |Go directly to the results meeting

① “PEEK neurosurgical products have obvious performance advantages over traditional titanium products. In recent years, with continuous market education and marketing promotion, the penetration rate of PEEK material products has increased year by year.” ② The successive implementation of collection has led to a decline in terminal prices, forcing the price of Kangtuo medical products to drop year-on-year in regions where collection has not yet been carried out.

cls.cnApr 23 18:39